Systems immunology of human malaria

Trends in Parasitology

Volumn 28, Issue 6, 2012, Pages 248-257

  Tran, Tuan M ^a   Samal, Babru ^a   Kirkness, Ewen ^b   Crompton, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

Author keywords

Malaria; Plasmodium falciparum; Systems immunology

Indexed keywords

ANTIBODY; CHEMOKINE; CHLOROQUINE; COMPLEMENTARY DNA; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 10; JANUS KINASE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MALARIA VACCINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; RTS S; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBODY TITER; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA SEQUENCE; GENE EXPRESSION; GENE PRODUCT; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOGENICITY; LIVER CELL; MALARIA CONTROL; MALARIA FALCIPARUM; MASS SPECTROMETRY; MEDICAL RESEARCH; MEROZOITE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; SPOROZOITE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 84861528263     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2012.03.006     Document Type: Review

References (105)

1. Murray C.J., et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
2. O'Meara W.P., et al. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect. Dis. 2010, 10:545-555.
3. Ranson H., et al. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control?. Trends Parasitol. 2011, 27:91-98.
4. Dondorp A.M., et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
5. Agnandji S.T., et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 2011, 365:1863-1875.
6. Langhorne J., et al. Immunity to malaria: more questions than answers. Nat. Immunol. 2008, 9:725-732.
7. Roestenberg M., et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468-477.
8. Benoist C., et al. A plaidoyer for 'systems immunology'. Immunol. Rev. 2006, 210:229-234.
9. Mader U., et al. Comprehensive identification and quantification of microbial transcriptomes by genome-wide unbiased methods. Curr. Opin. Biotechnol. 2011, 22:32-41.
10. Lash G.E., Pinto L.A. Multiplex cytokine analysis technologies. Expert Rev. Vaccines 2010, 9:1231-1237.
11. Maecker H.T., et al. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 2012, 12:191-200.
12. Vigil A., et al. Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol. 2010, 5:241-251.
13. Lakshmanan V., et al. Metabolomics and malaria biology. Mol. Biochem. Parasitol. 2011, 175:104-111.
14. Aderem A., et al. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. mBio 2011, 2. e00325-e00310.
15. Germain R.N. Vaccines and the future of human immunology. Immunity 2010, 33:441-450.
16. Gaucher D., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 2008, 205:3119-3131.
17. Querec T.D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 2009, 10:116-125.
18. Nakaya H.I., et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 2011, 12:786-795.
19. Chaussabel D., et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008, 29:150-164.
20. Berry M.P., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
21. Pascual V., et al. A genomic approach to human autoimmune diseases. Annu. Rev. Immunol. 2010, 28:535-571.
22. Oakley M.S., et al. Molecular correlates of experimental cerebral malaria detectable in whole blood. Infect. Immun. 2011, 79:1244-1253.
23. Le Roch K.G., et al. Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol. 2012, 34:50-60. 10.1111/j.1365-3024.2011.01340.x.
24. Daily J.P., et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 2007, 450:1091-1095.
25. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
26. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
27. Palm N.W., Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 2009, 227:221-233.
28. Dufva M. Fabrication of DNA microarray. Methods Mol. Biol. 2009, 529:63-79.
29. Fan J.B., et al. Illumina universal bead arrays. Methods Enzymol. 2006, 410:57-73.
30. Wang Z., et al. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10:57-63.
31. Ozsolak F., et al. Direct RNA sequencing. Nature 2009, 461:814-818.
32. Labaj P.P., et al. Characterization and improvement of RNA-Seq precision in quantitative transcript expression profiling. Bioinformatics 2011, 27:i383-i391.
33. Tariq M.A., et al. Whole-transcriptome RNAseq analysis from minute amount of total RNA. Nucleic Acids Res. 2011, 39:e120.
34. Gstaiger M., Aebersold R. Applying mass spectrometry-based proteomics to genetics, genomics and network biology. Nat. Rev. Genet. 2009, 10:617-627.
35. Kall L., Vitek O. Computational mass spectrometry-based proteomics. PLoS Comput. Biol. 2011, 7:e1002277.
36. Craig-Schapiro R., et al. Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS ONE 2011, 6:e18850.
37. Armah H.B., et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malaria J. 2007, 6:147.
38. Jain V., et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malaria J. 2008, 7:83.
39. Olszewski K.L., et al. Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 2010, 466:774-778.
40. Marsh K., et al. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 1995, 332:1399-1404.
41. Marsh K., Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006, 28:51-60.
42. Balog C.I., et al. Metabonomic investigation of human Schistosoma mansoni infection. Mol. Biosyst. 2011, 7:1473-1480.
43. Nita-Lazar A. Quantitative analysis of phosphorylation-based protein signaling networks in the immune system by mass spectrometry. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011, 3:368-376.
44. Cohen S., et al. Gamma-globulin and acquired immunity to human malaria. Nature 1961, 192:733-737.
45. Ornatsky O., et al. Highly multiparametric analysis by mass cytometry. J. Immunol. Methods 2010, 361:1-20.
46. Bendall S.C., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
47. Chaussabel D., et al. Assessing the human immune system through blood transcriptomics. BMC Biol. 2010, 8:84.
48. Abbas A.R., et al. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS ONE 2009, 4:e6098.
49. Repsilber D., et al. Biomarker discovery in heterogeneous tissue samples-taking the in-silico deconfounding approach. BMC Bioinformatics 2010, 11:27.
50. Shen-Orr S.S., et al. Cell type-specific gene expression differences in complex tissues. Nat. Methods 2010, 7:287-289.
51. Carrol E.D., et al. Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol. 2007, 8:20.
52. Traore B., et al. The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine 2009, 27:7299-7303.
53. Rappuoli R., Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 2011, 473:463-469.
54. Doolan D.L., et al. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009, 22:13-36. Table of Contents.
55. Hoffman S.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 2002, 185:1155-1164.
56. Gupta S., et al. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 1999, 5:340-343.
57. Crompton P.D., et al. Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria. J. Infect. Dis. 2008, 198:1265-1275.
58. Xiao W., et al. A genomic storm in critically injured humans. J. Exp. Med. 2011, 208:2581-2590.
59. Griffiths M.J., et al. Genomewide analysis of the host response to malaria in Kenyan children. J. Infect. Dis. 2005, 191:1599-1611.
60. Ockenhouse C.F., et al. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect. Immun. 2006, 74:5561-5573.
61. Franklin B.S., et al. Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5789-5794.
62. Weiss G.E., et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 2010, 6:e1000912.
63. Balazsi G., et al. Cellular decision making and biological noise: from microbes to mammals. Cell 2011, 144:910-925.
64. Pulendran B., et al. Systems vaccinology. Immunity 2010, 33:516-529.
65. Amit I., et al. Strategies to discover regulatory circuits of the mammalian immune system. Nat. Rev. Immunol. 2011, 11:873-880.
66. Nakaya H.I., Pulendran B. Systems vaccinology: its promise and challenge for HIV vaccine development. Curr. Opin. HIV AIDS 2012, 7:24-31.
67. Thera M.A., et al. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 2011, 365:1004-1013.
68. Bucasas K.L., et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J. Infect. Dis. 2011, 203:921-929.
69. Ramasamy A., et al. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 2008, 5:e184.
70. Malaria Genomic Epidemiology Network A global network for investigating the genomic epidemiology of malaria. Nature 2008, 456:732-737.
71. Moorthy V.S., et al. Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. Vaccine 2009, 27:5719-5725.
72. Sauerwein R.W., et al. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat. Rev. Immunol. 2011, 11:57-64.
73. Epstein J.E., et al. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J. Infect. Dis. 2007, 196:145-154.
74. Casares S., et al. The RTS,S malaria vaccine. Vaccine 2010, 28:4880-4894.
75. Roestenberg M., et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011, 377:1770-1776.
76. Suarez-Farinas M., et al. Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA). PLoS ONE 2010, 5:e10247.
77. Guilbride D.L., et al. Malaria's deadly secret: a skin stage. Trends Parasitol. 2012, 28:142-150.
78. Mardis E.R. The $1,000 genome, the $100,000 analysis?. Genome Med. 2010, 2:84.
79. Schadt E.E., et al. Computational solutions to large-scale data management and analysis. Nat. Rev. Genet. 2010, 11:647-657.
80. Stephan C., et al. Using Laboratory Information Management Systems as central part of a proteomics data workflow. Proteomics 2010, 10:1230-1249.
81. Fowkes F.J., et al. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis. PLoS Med. 2010, 7:e1000218.
82. Gardner M.J., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
83. Crompton P.D., et al. Advances and challenges in malaria vaccine development. J. Clin. Invest. 2010, 120:4168-4178.
84. Davies D.H., et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:547-552.
85. Tsuboi T., et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 2008, 76:1702-1708.
86. Doolan D.L., et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
87. Crompton P.D., et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:6958-6963.
88. Doolan D.L. Plasmodium immunomics. Int. J. Parasitol. 2011, 41:3-20.
89. Wrammert J., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
90. Cardoso F.C., et al. Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale. PLoS ONE 2011, 6:e27666.
91. Jing L., et al. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J. Clin. Invest. 2012, 122:654-673. 10.1172/JCI60556.
92. Jing L., et al. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J. Immunol. Methods 2009, 347:36-45.
93. Bruning O., et al. RNA isolation for transcriptomics of human and mouse small skin biopsies. BMC Res. Notes 2011, 4:438.
94. Di Meglio P., et al. The multitasking organ: recent insights into skin immune function. Immunity 2011, 35:857-869.
95. Chen A.A., et al. Humanized mice with ectopic artificial liver tissues. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11842-11847.
96. Buffet P.A., et al. Ex-vivo perfusion of human spleens maintains clearing and processing functions. Blood 2006, 107:3745-3752.
97. Rogerson S.J., et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect. Dis. 2007, 7:105-117.
98. Umbers A.J., et al. Malaria in pregnancy: small babies, big problem. Trends Parasitol. 2011, 27:168-175.
99. Muehlenbachs A., et al. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J. Immunol. 2007, 179:557-565.
100. Uematsu S., et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 2008, 9:769-776.
101. Hall J.A., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
102. Mazmanian S.K., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
103. Clarke T.B., et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
104. Stecher B., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007, 5:2177-2189.
105. Li J.V., et al. Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J. Proteome Res. 2008, 7:3948-3956.